On October 6, 2026 Arovella reported that it will be presenting at the Cell and Gene Meeting on the Mesa in Phoenix, Arizona.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cell and Gene Meeting is organised by the Alliance for Regenerative Medicine. It is the leading annual conference for the cell and gene therapy sector, bringing together senior executives and industry leaders to advance the development of innovative therapies. It is a chance for Arovella to present to an estimated 1500 attendees from regulators, investors and like-minded researchers and companies.

Arovella’s presentation will be delivered as part of the Innovation Spotlight program, which highlights the latest scientific, clinical, manufacturing, regulatory and commercial advancements from organisations across the advanced therapies ecosystem. The presentation will be delivered by Arovella’s Acting Chief Executive Officer, Dr Nicole van der Weerden.

(Press release, Arovella Therapeutics, OCT 6, 2026, View Source [SID1234673209])